Trade Summary

4 days ago, Brumm Joshua T, serving as Chief Executive Officer at CRESCENT BIOPHARMA, INC. (CBIO), sold 42,305 shares at $17.99 per share, for a total transaction value of $761,066.95. Following this transaction, Brumm Joshua T now holds 281,212 shares of CBIO.

This sale represents a 13.08% decrease in Brumm Joshua T's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 at 4:01 PM ET, 1 day after the trade was made.

CRESCENT BIOPHARMA, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.